Kawabori M, Kurihara C, Conyer RT, et al. Effect of concomitant mitral valve procedures for severe mitral regurgitation during left ventricular assist device implantation. J Artif Organs. 2019;22(2):91–7. https://doi.org/10.1007/s10047-018-1076-8.
Robertson JO, Naftel DC, Myers SL, et al. Concomitant mitral valve procedures in patients undergoing implantation of continuous-flow left ventricular assist devices: an INTERMACS database analysis. J Heart Lung Transplant. 2018;37(1):79–88. https://doi.org/10.1016/j.healun.2017.09.016.
Stulak JM, Tchantchaleishvili V, Haglund NA, et al. Uncorrected pre-operative mitral valve regurgitation is not associated with adverse outcomes after continuous-flow left ventricular assist device implantation. J Heart Lung Transplant. 2015;34(5):718–23. https://doi.org/10.1016/j.healun.2014.11.023.
Alnsasra H, Asleh R, Schettle SD, et al. Diastolic pulmonary gradient as a predictor of right ventricular failure after left ventricular assist device implantation. J Am Heart Assoc. 2019;8(16):e012073. https://doi.org/10.1161/JAHA.119.012073.
Article PubMed PubMed Central Google Scholar
Imamura T, Kinugawa K, Kinoshita O, Nawata K, Ono M. High pulmonary vascular resistance in addition to low right ventricular stroke work index effectively predicts biventricular assist device requirement. J Artif Organs. 2016;19(1):44–53. https://doi.org/10.1007/s10047-015-0867-4.
Tedford RJ, Beaty CA, Mathai SC, et al. Prognostic value of the pre-transplant diastolic pulmonary artery pressure-to-pulmonary capillary wedge pressure gradient in cardiac transplant recipients with pulmonary hypertension. J Heart Lung Transplant. 2014;33(3):289–97. https://doi.org/10.1016/j.healun.2013.11.008.
Mehra MR, Canter CE, Hannan MM, et al. The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: a 10-year update. J Heart Lung Transplant. 2016;35(1):1–23. https://doi.org/10.1016/j.healun.2015.10.023.
Lim HS, Howell N, Ranasinghe A. The effect of left ventricular assist device therapy in patients with heart failure and mixed pulmonary hypertension. Int J Artif Organs. 2017;40(2):67–73. https://doi.org/10.5301/ijao.5000556.
Mikus E, Stepanenko A, Krabatsch T, et al. Reversibility of fixed pulmonary hypertension in left ventricular assist device support recipients. Eur J Cardiothorac Surg. 2011;40(4):971–7. https://doi.org/10.1016/j.ejcts.2011.01.019.
Selim AM, Wadhwani L, Burdorf A, et al. Left ventricular assist devices in Pulmonary Hypertension Group 2 with significantly elevated pulmonary vascular resistance: a bridge to cure. Heart Lung Circ. 2019;28(6):946–52. https://doi.org/10.1016/j.hlc.2018.04.299.
Tsukashita M, Takayama H, Takeda K, et al. Effect of pulmonary vascular resistance before left ventricular assist device implantation on short- and long-term post-transplant survival. J Thorac Cardiovasc Surg. 2015;150(5):1352–60. https://doi.org/10.1016/j.jtcvs.2015.07.012.
Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;62(16):e147-239. https://doi.org/10.1016/j.jacc.2013.05.019.
Zoghbi WA, Enriquez-Sarano M, Foster E, et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr. 2003;16(7):777–802. https://doi.org/10.1016/S0894-7317(03)00335-3.
Zoghbi WA, Adams D, Bonow RO, et al. Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr. 2017;30(4):303–71. https://doi.org/10.1016/j.echo.2017.01.007.
Kormos RL, Antonides CFJ, Goldstein DJ, Cowger JA, Starling RC, Kirklin JK, Rame JE, Rosenthal D, Mooney ML, Caliskan K, Messe SR, Teuteberg JJ, Mohacsi P, Slaughter MS, Potapov EV, Rao V, Schima H, Stehlik J, Joseph S, Pagani FD. Updated definitions of adverse events for trials and registries of mechanical circulatory support: A consensus statement of the mechanical circulatory support academic research consortium. The Journal of Heart and Lung Transplantation. 2020;39(8):735–50. https://doi.org/10.1016/j.healun.2020.03.010.
Sapir-Pichhadze R, Pintilie M, Tinckam KJ, et al. Survival analysis in the presence of competing risks: the example of waitlisted kidney transplant candidates. Am J Transplant. 2016;16(7):1958–66. https://doi.org/10.1111/ajt.13717.
Austin PC, Lee DS, Fine JP. Introduction to the analysis of survival data in the presence of competing risks. Circulation. 2016;133(6):601–9. https://doi.org/10.1161/CIRCULATIONAHA.115.017719.
Article PubMed PubMed Central Google Scholar
Briasoulis A, Inampudi C, Akintoye E, et al. Trends in utilization, mortality, major complications, and cost after left ventricular assist device implantation in the United States (2009 to 2014). Am J Cardiol. 2018;121(10):1214–8. https://doi.org/10.1016/j.amjcard.2018.01.041.
Fukuhara S, Takeda K, Chiuzan C, et al. Concomitant mitral repair and continuous-flow left ventricular assist devices: is it warranted? J Thorac Cardiovasc Surg. 2017;154(4):1303–12. https://doi.org/10.1016/j.jtcvs.2017.04.021.
Mehra MR, Uriel N, Naka Y, et al. A fully magnetically levitated left ventricular assist device — final report. N Engl J Med. 2019;380(17):1618–27. https://doi.org/10.1056/NEJMoa1900486.
Rogers JG, Pagani FD, Tatooles AJ, et al. Intrapericardial left ventricular assist device for advanced heart failure. N Engl J Med. 2017;376(5):451–60. https://doi.org/10.1056/NEJMoa1602954.
Kapelios CJ, Lund LH, Wever-Pinzon O, et al. Right heart failure following left ventricular device implantation: natural history, risk factors, and outcomes: an analysis of the STS INTERMACS database. Circ Heart Fail. 2022;15(6):e008706. https://doi.org/10.1161/CIRCHEARTFAILURE.121.008706.
Article PubMed PubMed Central Google Scholar
Maron BA, Brittain EL, Hess E, et al. Pulmonary vascular resistance and clinical outcomes in patients with pulmonary hypertension: a retrospective cohort study. Lancet Respir Med. 2020;8(9):873–84. https://doi.org/10.1016/S2213-2600(20)30317-9.
Article PubMed PubMed Central Google Scholar
Krishnamurthy Y, Cooper LB, Parikh KS, et al. Pulmonary hypertension in the era of mechanical circulatory support. ASAIO J. 2016;62(5):505–12. https://doi.org/10.1097/MAT.0000000000000408.
留言 (0)